You are here

Article info

Article menu
Download PDFPDF
Editorial
Ivabradine is cost-effective in the treatment of chronic heart failure

Authors

  1. Correspondence to Professor Stephen Morris, Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7HB, UK; steve.morris{at}ucl.ac.uk
View Full Text

Citation

Morris S, Hunter R
Ivabradine is cost-effective in the treatment of chronic heart failure
Heart 2014;100:991-992.

Publication history

  • Received March 19, 2014
  • Accepted March 22, 2014
  • First published April 15, 2014.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions